BioWorld Asia

Jan. 20, 2010

BioInvent to Get $21M in Directed Share Offer with Little Discount

BioInvent International AB is pocketing around SEK150 million (US$21.2 million) - before expenses - and making two prominent additions to its shareholders' register, via a directed offering of 5,434,800 shares. Read More

Comments from EU Health Chief Designate Has Industry on Edge

Wellcome Trust Offers Bonanza of Sequencing, Genome Data

BioMedPartners Closes $102M Fund for Early- Mid-Stage EU Companies

U.S. Scientific Inventory Shows Asia, EU Gaining in R&D Status

40 UK Companies Will Share in £8.3M Stem Cell Program

Rapid U.S. Biomedical Research Funding Is Dead: JAMA Report

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 3, 2026

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

BioWorld Science

Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...